Clinical trialNAUnknown
RFA for Malignant Biliary Obstruction
Radiofrequency Ablation Plus Stenting Versus Stenting Alone for Treatment of Malignant Biliary Obstruction
- Outcome
- Outcome unknown
- Phase
- NA
- Status
- Unknown
- Study type
- Interventional
- Start
- 8 June 2017
- Expected end
- 8 May 2020
- Enrollment
- 140 participants
- Sites
- 1
- Primary outcomes
- Survival
- Sponsor
- Other gov
- Results posted
- No
- Last update
- 30 May 2017
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 4
- Builds on itEndoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial. DOI 10.1136/gutjnl-2023-329700↗
- BackgroundAnalysis of Endoscopic Radiofrequency Ablation of Biliary Malignant Strictures in Pancreatic Cancer Suggests Potential … DOI 10.1007/s10620-015-3731-8↗
- BackgroundComparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictur… DOI 10.1007/s10620-014-3264-6↗
- BackgroundPancreatic cancer. DOI 10.1016/s0140-6736(10)62307-0↗